Showing results (311-320 of 2,885) with videos related to
Sort By:
Pageof 289
Current Pharmaceutical Design|December 8, 2004
Endothelial dysfunction: methods of assessment and application to hypertensionSunil Nadar, Andrew D Blann, Gregory Y H LipAnnals of Clinical Biochemistry|September 25, 2003
Primary hyperaldosteronismSunil Nadar, Gregory Y H Lip, D Gareth BeeversExpert Opinion on Investigational Drugs|May 2, 2003
Factor X inhibitorsKiat Tsong Tan, Andrew Makin, Gregory Y H LipExpert Opinion on Investigational Drugs|May 2, 2003
The METHRO trialsAli Hamaad, Muzahir H Tayebjee, Gregory Y H LipCerebrovascular Diseases (Basel, Switzerland)|July 28, 2021
Relationship between Chronic Kidney Disease, Time-in-Therapeutic Range, and Adverse Outcomes in Atrial Fibrillation: A post hoc Analysis from the AMADEUS TrialWern Yew Ding, Gregory Y H Lip, Alena ShantsilaCurrent Hypertension Reports|October 28, 2016
Effects of Aspirin on Endothelial Function and HypertensionMikhail S Dzeshka, Alena Shantsila, Gregory Y H LipEbiomedicine|July 19, 2016
Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF TrialsMarco Proietti, Deirdre A Lane, Gregory Y H LipHypertension (Dallas, Tex. : 1979)|June 5, 2003
Pharmacological modulation of platelet function in hypertensionAndrew D Blann, Sunil Nadar, Gregory Y H LipAnnals of Medicine|October 16, 2007
The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunctionChristopher J Boos, Balu Balakrishnan, Gregory Y H LipThe American Journal of Cardiology|September 11, 2007
Endotoxemia, inflammation, and atrial fibrillationChristopher J Boos, Gregory Y H Lip, Bernd JilmaPageof 289